Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
Orphan Designation for Silence’s β-Thalassemia Drug
Silence Therapeutics’ lead candidate SLN124 has secured orphan drug designation in the European Union for the treatment of β-Thalassemia. The designation to SLN124 was granted by the Committee for ...
MHRA Approved Upperton New Facilities
Spray drying specialist has invested in building enhancements and in the expansion of its processing and analytical capabilities The UK Medicines and Healthcare products Regulatory Agency (MHRA) ha...
Men in UK Sentenced for Illegal Supply of Meds
Three people have been handed custodial sentences in England for their involvement in the illegal supply of potentially dangerous prescription-only medicines. Jagdiep Dhonsi, Amrin Mirza and Shirin...
Risk for Pharma after Brexit still Unknown
A ‘no deal’ Brexit will change and burden how all industries that move materials and goods across borders, including the pharmaceutical and medical device sectors, do business. Pharmaceutical compa...
UK MHRA clarified cross-contamination Control Requirements
With the introduction of the Permitted Daily Exposure (PDE) values in conjunction with questions on cross contamination and on cleaning validation, the EMA began a new chapter a few years ago. This is...
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
V.P. Filatov Pharmaceutical Plant
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
New Treatment of Idiopathic Pulmonary Fibrosis
Alternative Technologies of Removing Catalysts from API
FDA Predicts Rapid Development of Cell and Gene Therapies
Subscribe to Newsletter!
© GMP news